EUVIMEDEUVIMED entdecken
Crossref

Interferon regulatory factor-1–expressing astrocytes are epigenetically controlled and exacerbate TBI-associated pathology in mice

Wenxing Cui iD, Hao Bai iD, Chengxuan Guo iD, Jinpeng Zhou iD, Dayun Feng iD, Shiji Zhang, Fei Gao iD, Liying Han, Yang Tian, Jingyu Dong, Feilong Wei iD, Jian Bai iD und 12 weitere

Science Translational Medicine · 28.05.2025 · 17 (800)

DOI: 10.1126/scitranslmed.adr5300 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Translational Medicine, erschienen am 28.05.2025. Verfasst von Wenxing Cui und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Tangdu Hospital, Fourth Military Medical University, Xi'an, 710038 Shaanxi, China. Hauptthemen laut MEDLINE: Astrocytes, Brain Injuries, Traumatic, Epigenesis, Genetic, Interferon Regulatory Factor-1. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 62 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Astrocyte heterogeneity is closely associated with the pathophysiology of traumatic brain injury (TBI), particularly in the development of cerebral edema, which is a major contributor to morbidity and mortality in patients with TBI. However, little is known about how certain astrocyte subpopulations contribute to the development of cerebral edema after acute brain injury. Using multiomics approaches, we identified a proinflammatory interferon regulatory factor-1–positive (IRF1 + ) astrocyte cluster that correlates with clinical severity and outcomes in patients with TBI. Mechanistically, IRF1 in astrocytes binds to promoters of inflammatory cytokine genes, driving neurotoxicity and disrupting endothelial tight junction integrity. Using Aldh1l1 CreERT2 ; Irf1 flox/flox mice, we demonstrated that astrocyte-specific deletion of Irf1 mitigates astrocyte-mediated pathogenic activities, ameliorates blood-brain barrier (BBB) disruption, and reduces cerebral edema after TBI. Moreover, enhanced IRF1 activity in astrocytes facilitates the recruitment of CD8 + T cells by releasing C-X-C motif chemokine ligand 10 (CXCL10), which exacerbates BBB disruption and cerebral edema. Furthermore, we identified tet methylcytosine dioxygenase 3 (TET3)–mediated DNA hydroxymethylation as a key epigenetic mechanism that up-regulates IRF1 expression in astrocytes, thereby activating proinflammatory transcriptional programs. Finally, we developed an IRF1 antagonist, 8003-3282, which effectively reduces inflammation, preserves BBB integrity, alleviates cerebral edema, and improves neurological outcomes in a TBI mouse model. These findings highlight IRF1 + astrocytes as critical mediators of TBI-associated pathology and suggest that targeting this astrocyte cluster may represent a promising therapeutic strategy to mitigate inflammation, BBB damage, and cerebral edema in TBI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AstrocytesBrain Injuries, TraumaticEpigenesis, GeneticInterferon Regulatory Factor-1AnimalsBlood-Brain BarrierMiceMice, Inbred C57BLMaleBrain EdemaHumans

Substanzen

Interferon Regulatory Factor-1Irf1 protein, mouse

Autor:innen und Institutionen

  • Department of Neurosurgery, Tangdu Hospital, Fourth Military Medical University, Xi'an, 710038 Shaanxi, China.
  • Department of Orthopaedics, Tangdu Hospital, Fourth Military Medical University, Xi'an, 710038 Shaanxi, China.
  • Bioinformatics Center of AMMS, Beijing 100850, China.
  • Department of Neurosurgery, 983th Hospital of the Joint Logistic Support Force, Tianjin 300143, China.

ORCID-Profile: Wenxing Cui, Hao Bai, Chengxuan Guo, Jinpeng Zhou, Dayun Feng, Fei Gao, Feilong Wei, Jian Bai, Xun Wu, Liang Wang, Wei Guo, Tianzhi Zhao, Qing Cai, Haixiao Liu, Shunnan Ge, Yan Qu

Zitieren

APA

Cui, W., Bai, H., Guo, C., Zhou, J., Feng, D., Zhang, S., Gao, F., Han, L., Tian, Y., Dong, J., Wei, F., Bai, J., Wu, X., Shi, Y., Guo, H., Wang, L., Li, Z., Guo, W., Zhao, T., …, & Qu, Y. (2025). Interferon regulatory factor-1–expressing astrocytes are epigenetically controlled and exacerbate TBI-associated pathology in mice. Science Translational Medicine, 17(800). https://doi.org/10.1126/scitranslmed.adr5300

Vancouver

Cui W, Bai H, Guo C, Zhou J, Feng D, Zhang S, et al. Interferon regulatory factor-1–expressing astrocytes are epigenetically controlled and exacerbate TBI-associated pathology in mice. Science Translational Medicine. 2025;17(800). doi:10.1126/scitranslmed.adr5300

BibTeX
@article{Cui2025,
  author = {Cui, Wenxing and Bai, Hao and Guo, Chengxuan and Zhou, Jinpeng and Feng, Dayun and Zhang, Shiji and Gao, Fei and Han, Liying and Tian, Yang and Dong, Jingyu and Wei, Feilong and Bai, Jian and Wu, Xun and Shi, Yingwu and Guo, Hao and Wang, Liang and Li, Zhihong and Guo, Wei and Zhao, Tianzhi and Heng, Lijun and Cai, Qing and Liu, Haixiao and Ge, Shunnan and Qu, Yan},
  title = {Interferon regulatory factor-1–expressing astrocytes are epigenetically controlled and exacerbate TBI-associated pathology in mice},
  journal = {Science Translational Medicine},
  year = {2025},
  volume = {17},
  number = {800},
  doi = {10.1126/scitranslmed.adr5300}
}
Kostenlos starten →